Galenica AG Stock – Fundamental Analysis

Price
85.65
10/14/2026
Apr 2017
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 3/22/2026)

Balance Sheet Total Assets 3,344,460,000.00 ROE 44.31 %
Balance Sheet Total Equity 1,481,900,000.00 ROA 5.41 %
Cashflow Capital Expenditures -27,411,000.00 P/FCF 15.69
Cashflow Free Cash Flow 272,353,984.00 – –
Cashflow Operating Cash Flow 299,765,000.00 P/CF 14.25
Income Earnings per Share (diluted) 3.63 Div. Yield 1.46 %
Income Net Income 181,099,000.00 P/E 23.60
Income Shares Outstanding 49,887,000.00 P/B 2.88
Income Total Revenue 4,135,620,000.00 P/S 1.03

Ratios calculated on: 10/14/2026

Company Description

Galenica AG operates as a healthcare provider in Switzerland and internationally. It operates through two segments, Health & Beauty, and Services. The Health & Beauty segment operates 522 pharmacies, including 366 owned pharmacies and 156 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Services segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics services for the healthcare market; master data for the healthcare market; management software solutions for pharmacies; and develops tools to securely manage, communicate, and distribute sensitive health data and enhance patient safety. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.galenica.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more